We are excited to be sponsoring and involved in the Alliance for Regenerative Medicine's (ARM) Cell and Gene Meeting on the Mesa in Carlsbad, California on October 10-12.
Join senior leaders in cell and gene therapy, gene editing and tissue engineering for the sector's premier conference and hear from leading industry experts involved in panels ranging from next-generation platform technologies to the benefits of early patient engagement in cell and gene therapy development.
Speaking from Cell and Gene Therapy Catapult:
SCIENCE SLAM: ROAD TO SCALABILITY AND ACCESS TO iPSC-DERIVED THERAPIES
October 10, 11:15am – 12:15pm | Ecolab Life Sciences Ballroom
iPSC-derived therapies are heralded as the panacea for allogeneic therapies and have the potential to provide scalability, economy and access to patients around the globe. However, many hurdles remain around manufacturing, regulations and market access. This session will discuss approaches and next steps towards commercialization of PSC-based therapies, including manufacturing innovations for scale, product characterization, as well as regulatory perspectives around starting materials.
Chair:
Jacqueline Barry, Ph.D., Chief Clinical Officer, Cell and Gene Therapy Catapult
‘Closing the Cell and Gene Therapy Workforce Gap’
October 10, 1:15pm – 14:00pm |
ARM released its Workforce Report Gap Analysis for the Cell and Gene Therapy Sector, highlighting how the need for continued investment into developing a skilled workforce for the sector is key in enabling patient access to these advanced therapeutics across the United States (US). This panel will discuss current barriers to effective workforce education and provide strategies for scaling successful training models across the US and worldwide.
Panellist:
Stephen Ward, Chief Manufacturing Officer, Cell and Gene Therapy Catapult
If you would like to schedule a meeting with a team member, please contact us at communications@ct.catapult.org.uk